It is caused by abnormal blood vessel growth (a condition referred to as 'wet' macular degeneration) or atrophy and accumulation of debris ('dry' macular degeneration), both of which damage the ...
Prevent Blindness announces its fourth annual Geographic Atrophy Awareness Week, December 2 to 8, 2024. The organization ...
The following is a summary of “Phase 1 Study of JNJ-81201887 Gene Therapy in Geographic Atrophy Secondary to Age-Related ...
Findings from a post hoc analysis of the AREDS and AREDS2 studies were presented at the recent American Academy of ...
Geographic atrophy (GA) is the advanced stage of age-related macular degeneration. While certain factors, like age and genetics, can increase your risk, others, like not smoking, may help slow or ...
A new study has linked moderate-to-severe obstructive sleep apnea (OSA), characterized by low oxygen levels overnight, with an increased risk of developing wet age-related macular degeneration (AMD).
Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...
Key findings include reduced lesion growth, retinal tissue preservation, and improved visual function, demonstrating ...
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the supplemental new drug ...
The U.S. FDA issued a complete response letter Nov. 15 for Izervay’s (avacincaptad pegol intravitreal solution, ACP) supplemental NDA, which sought to include positive two-year data for the Astellas ...